Stock Information
Praxis Precision Medicines Inc (PRAX)
Ticker Symbol: PRAX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $7,761.73 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -13.4539
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -58.74%
Latest News
-
Apellis Pharmaceuticals, Centessa Pharmaceuticals, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
Tue, Mar 31, 2026 9:57 AM
-
Praxis Precision Medicines shares are trading higher after the FDA accepted for priority review the company's New Drug Application for relutrigine, for the treatment of SCN2A and SCN8A developmental and epileptic encephalopathies
Tue, Mar 31, 2026 8:52 AM
-
FDA Accepted Praxis Precision Medicines NDA For Relutrigine For Priority Review
Mon, Mar 30, 2026 4:05 PM
Key Financials
Financial data not available
